Παρακολούθηση
Misha Riley
Misha Riley
Research Associate at MGH
Η διεύθυνση ηλεκτρονικού ταχυδρομείου έχει επαληθευτεί στον τομέα nmr.mgh.harvard.edu
Τίτλος
Παρατίθεται από
Παρατίθεται από
Έτος
Evidence for brain glial activation in chronic pain patients
ML Loggia, DB Chonde, O Akeju, G Arabasz, C Catana, RR Edwards, ...
Brain 138 (3), 604-615, 2015
4662015
AKT kinase activity is required for lithium to modulate mood-related behaviors in mice
JQ Pan, MC Lewis, JK Ketterman, EL Clore, M Riley, KR Richards, ...
Neuropsychopharmacology 36 (7), 1397-1411, 2011
1322011
HDAC6 Brain Mapping with [18F]Bavarostat Enabled by a Ru-Mediated Deoxyfluorination
MG Strebl, AJ Campbell, WN Zhao, FA Schroeder, MM Riley, ...
ACS central science 3 (9), 1006-1014, 2017
682017
PET neuroimaging reveals histone deacetylase dysregulation in schizophrenia
TM Gilbert, NR Zürcher, CJ Wu, A Bhanot, BG Hightower, M Kim, ...
The Journal of clinical investigation 129 (1), 364-372, 2019
642019
Investigating convergent actions of genes linked to familial Parkinson’s disease
B Wolozin, S Saha, M Guillily, A Ferree, M Riley
Neurodegenerative Diseases 5 (3-4), 182-185, 2008
472008
Class I HDAC imaging using [3H] CI-994 autoradiography
Y Wang, YL Zhang, K Hennig, JP Gale, Y Hong, A Cha, M Riley, ...
Epigenetics 8 (7), 756-764, 2013
322013
FDG-PET imaging reveals local brain glucose utilization is altered by class I histone deacetylase inhibitors
FA Schroeder, DB Chonde, MM Riley, CK Moseley, ML Granda, ...
Neuroscience letters 550, 119-124, 2013
172013
Nasal neuron PET imaging quantifies neuron generation and degeneration
GC Van de Bittner, MM Riley, L Cao, J Ehses, SP Herrick, EL Ricq, ...
The Journal of clinical investigation 127 (2), 681-694, 2017
122017
CN133, a novel brain-penetrating histone deacetylase inhibitor, hampers tumor growth in patient-derived pediatric posterior fossa ependymoma models
R Antonelli, C Jiménez, M Riley, T Servidei, R Riccardi, A Soriano, ...
Cancers 12 (7), 1922, 2020
72020
Identification and prioritization of PET neuroimaging targets for microglial phenotypes associated with microglial activity in Alzheimer’s disease
ND Bartolo, N Mortimer, MA Manter, N Sanchez, M Riley, TT O’Malley, ...
ACS Chemical Neuroscience 13 (24), 3641-3660, 2022
32022
Using Proteomics Analysis to Identify Cerebrospinal Fluid Biomarkers in Normal Pressure Hydrocephalus
K LaCasse, MB de Geus, BA Trombetta, CE Ramirez, LH El‐Mufti, ...
Alzheimer's & Dementia 18, e067160, 2022
12022
A pilot multiple crossover, randomized controlled trial of methylphenidate in mild cognitive impairment using standardized tests and daily brain games to track cognition …
LA DesRuisseaux, VJ Williams, AJ McManus, AS Gupta, AM Bolling, ...
Alzheimer's & Dementia 16, e043188, 2020
12020
Feasibility of common, enjoyable game play for assessing daily cognitive functioning in older adults
N Schwab, CY Wu, J Galler, T DeRamus, A Ford, J Gerber, R Kitchen, ...
Frontiers in Neurology 14, 1258216, 2023
2023
A multimodal pilot study of default mode network (DMN) connectivity across the lifespan in healthy volunteers using functional imaging, CSF, and plasma Alzheimer's disease …
NL Shapiro, JA Galler, BA Trombetta, K LaCasse, CE Ramirez, MM Riley, ...
Alzheimer's & Dementia 18, e066591, 2022
2022
Evaluating the biological variability of blood‐based biomarkers for use in clinical trials
BA Trombetta, SW Allen, LH El‐Mufti, MM Riley, CE Ramirez, M Weik, ...
Alzheimer's & Dementia 18, e066629, 2022
2022
Pre-clinical evaluation of novel COX-2 PET radiotracers for imaging neuroimmune dysregulation
MS Placzek, M Weiwer, MM Riley, DK Wilton, F Wagner, B Stevens, ...
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM 41 (1_ SUPPL), 262-263, 2021
2021
IC‐P‐166: Olfactory Sensory Neuron Monitoring in Alzheimer’s Disease: Toward Human Translation of a Pet Imaging Agent
GC Van de Bittner, MM Riley, L Cao, J Ehses, HY Wey, R Neelamegam, ...
Alzheimer's & Dementia 12, P122-P122, 2016
2016
[11C] Neuroflux: In Vivo Measurement of Neuron Population Flux
G Van de Bittner, M Riley, L Cao, J Ehses, S Herrick, E Ricq, J Smith, ...
NEUROPSYCHOPHARMACOLOGY 40, S198-S199, 2015
2015
Evaluating a Novel Brain-penetrant HDAC Inhibitor in Rat Behavioral Models in Relation to Target Occupancy Assessed by Pet Imaging
FA Schroeder, C Wang, MM Riley, S Reis, YL Zhang, SJ Haggarty, ...
NEUROPSYCHOPHARMACOLOGY 38, S578-S579, 2013
2013
Δεν είναι δυνατή η εκτέλεση της ενέργειας από το σύστημα αυτή τη στιγμή. Προσπαθήστε ξανά αργότερα.
Άρθρα 1–19